Destruction of 139,000 USD Worth of Counterfeit Goods in Ho Chi Minh City

Regulations by 2FIRSTS.ai
Mar.05.2024
Destruction of 139,000 USD Worth of Counterfeit Goods in Ho Chi Minh City
Vietnam's market authorities destroy over 37 billion dong worth of counterfeit and unsafe goods in Ho Chi Minh City.

According to recent reports from Vietnamese media, the market management authorities in Ho Chi Minh City have destroyed goods related to 62 administrative penalties issued by the 3rd team of the Market Management Bureau and the Ho Chi Minh City Market Management Bureau at the factory of the Green Environment Company in Binh Chanh district, Vietnam.

 

The total value of these goods exceeds 3.7 billion Vietnamese dong (approximately 1 million yuan, 139,000 USD), including 21,320 items of counterfeit, untraceable, and potentially harmful products imported from overseas that do not guarantee consumer health, such as clothing, food, cosmetics, shoes, e-cigarettes, hookahs, herbal medicines, etc.

 

The destruction process fully complies with environmental requirements, with the Ho Chi Minh City Market Management Authority (QLTT) and other relevant units closely monitoring the process.

 

At the same time, the processes of inspection, control, and administrative penalties, as well as supervision actions to destroy compensation goods, are part of the routine work of the Ho Chi Minh City Market Management Department. This is mainly to combat counterfeit, smuggling, unknown origin, and low-quality goods in their jurisdiction. It also ensures that all procedures and processes are carried out in accordance with regulations.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
InterTabac 2025 Insights|"0+10" Combination E-cigarettes Become a New Trend, VOZOL, smiss, MEGA BAR, and Others Launch New Products
InterTabac 2025 Insights|"0+10" Combination E-cigarettes Become a New Trend, VOZOL, smiss, MEGA BAR, and Others Launch New Products
At the InterTabac 2025 exhibition, brands like VOZOL, smiss, and MEGA BAR introduced a new trend with their "2+10" and "0+10" combination refillable e-cigarettes. These devices pair empty pods with 10ml e-liquid bottles, complying with German regulations while offering users greater flexibility.
Sep.20 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australian police seize tons of illicit tobacco and millions of cigarettes in Victoria's largest illegal tobacco case.
Sep.11 by 2FIRSTS.ai
Philip Morris International to Boost Investment in the Philippines, Aiming to Make It a Smoke-Free Products Export Hub
Philip Morris International to Boost Investment in the Philippines, Aiming to Make It a Smoke-Free Products Export Hub
PMI to make the Philippines a smoke-free export hub, citing strong regulation; upgrading local plants, expanding affordable supply; $14bn invested globally.
Oct.11 by 2FIRSTS.ai
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab will unveil its JuiSour Series at InterTabac in Dortmund, positioned around “aroma burst, sour-sweet balance,enhanced juiciness.” The new line comprises three sub-series — Berry, Candy, and Citrus — breaking through the limitations of traditional acetic acid and introducing the concept of a “Golden Sour-Sweet Ratio” to elevate the sour-aromatic profile and mouthfeel of e-liquids.
Sep.12